Selecting TARE particle

  • Stable Y89 is bombardment with neutron leads to formation of  Y90
  • Chemical separation from parent isotope Strontium 90
  • Yttrium 90 decays to Zirconium 90 
  • Near – pure emission of β particle (free electron emission)
    Small portion – decay through pair production (PET imaging)
  • Average energy – 933.7 KeV
  • Half Life – 64.2 hrs (2.67 days)
  • Path travelled 
    2.5 mm – (2/3rd particles), 
    5mm – 90% particles
    11 mm – Maximum distance upto which particle were detected

TARE PARTICLES:

Glass-SphereResin-Sphere
Material​Spherodized aluminum and silicon dioxide glass containing Yttrium-89 (Y89) subjected to neutron bombardment which activates Y89 into Y90​Biocompatible polymer coated with a cross-link cation exchange polystyrene resin ionically bound to Y90​
Leech effect​
(Bone deposition and Myelosuppression)​
Y90 is embedded in the glass matrix (minimal)​Y90 immobilized with phosphate salts, therefore Don’t use Ionic contrast or normal saline​ (only 0.01%-0.4% of released particles can cause myelosuppression)​
Specific Gravity​3.6 g/dl (settle down) (More force than native blood flow maybe required to inject the particles and causes diversion from low resistance tumor vessel to high resistance non-tumor vessel, Basciano)​1.6 g/dl (similar to blood therefore more uniform distribution) (more penetration seen in surrogate hepatic artery system, Jernigan)​
Size​15-35 um (95% particles)​29-35 um and intimately bound​
Activity Vial​

Not Updated
3 ,5, 7, 10,15, 20 GBq​

1.2 , 2 , 2.8, 4, 6, 8 million microsphere (respectively) Extended shelf life present (upto 12 days)​

vial cannot split and so entire vial must be injected
3 Gbq +/- 10% (at 6 PM the day following delivery to the institution and can be used up to 24 hours after calibration)​

40-80 million microspheres ​

(2 batches - 14 vials and 5 vials)
Specific Activity & Embolic Effect​High-Specific activity (2500Bq/particle)​
Mild radioembolic effect​
Low-Specific activity ​
(75 Bq/particle and 37.5 Bq/particle)​
Moderate/High radio embolic effect​
PVT (minimal embolic effect)​Indicated​May result in embolic occlusion of the parent vessel​
(Dose fractioning needed if used)​
  1. Arnold, Christoph Reinhold et al. “The Role of Cancer Stem Cells in Radiation Resistance.” Frontiers in oncology vol. 10 164. 20 Feb. 2020, doi:10.3389/fonc.2020.00164
  2.  
Skip to content